Illness	Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	264
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	218
Malignant neoplasm of prostate (C61)	181
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	173
Hyperplasia of prostate (N40)	143
Calculus of kidney and ureter - Calculus of kidney (N20.0)	102
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1)	86
Calculus of kidney and ureter - Calculus of ureter (N20.1)	81
Acute tubulo-interstitial nephritis (N10)	73
Other disorders of urinary system - Incontinence without sensory awareness (N39.42)	56

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	1.042
Computer-assisted analysis of the images with 3D-analysis (3-990)	651
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	622
Computed tomography (CT) of the abdomen without contrast medium (3-207)	475
Examination of the urethra and the urinary bladder by endoscopy (1-661)	434
(5-98k.0)	365
Insertion, exchange or removal of a ureteral stent (8-137.00)	352
Insertion, exchange or removal of a ureteral stent (8-137.10)	303
Special staining of the lining (mucosa) of the small and large intestine and the anal mucosa during endoscopy (1-655)	226
Ultrasound of the male reproductive organs with access through the urethra or anus (3-05c.0)	186

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
51	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
49	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
47	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	Prof. Dr. med. Bernhard Planz (Universität Wien)
Participation in multi-centre phase III/IV studies	Studien zu Nierentumoren durch die Klinik für Urologie und Kinderurologie
Initiation and management of uni-centric/multi-centric clinical/scientific studies	Studien zu Prostataerkrankungen, Hoden-, Nierentumoren, Harnsteine und Inkontinenz durch die Klinik für Urologie und Kinderurologie
Editors of scientific journals/textbooks
Doctoral supervision	Prof. Dr. med. Bernhard Planz, Klinik für Urologie und Kinderurologie

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)
HB03	Physical therapist / physiotherapist (m/f)
HB07	Surgical technical assistant (m/f)
HB17	Auxiliary nurse (m/f)	Krankenpflegeassistenz